As chemotherapy, including TOP1 poisons, remains the most effective treatment of SCLC patients, understanding the mechanisms triggered by anticancer TOP1 poisons can open novel opportunities to improve SCLC treatments. Here, TOP1 is linked to small cell lung carcinoma.